Unique Mechanism for a High-Risk Leukemia Researchers uncovered the aberrant mechanism underlying a notoriously treatment-resistant acute lymphoblastic leukemia subtype; findings offer lessons for understanding all cancers.Food Triggers Creation of Regulatory T Cells IBS researchers document how normal diet establishes immune tolerance conditions in the small intestine.Therapeutic Approach Gives Hope for Multiple Myeloma A new therapeutic approach tested by a team from Maisonneuve-Rosemont Hospital (CIUSSS-EST, Montreal) and the University of Montreal gives promising results for the treatment of multiple myeloma, a cancer of the bone marrow currently considered incurable with conventional chemotherapy and for which the average life expectancy is about 6 or 7 years.Cellular 'Relief Valve' A team led by scientists at The Scripps Research Institute (TSRI) has solved a long-standing mystery in cell biology by showing essentially how a key “relief-valve” in cells does its job.Switch Lets Salmonella Fight, Evade Immune System Researchers at the University of Illinois at Chicago have discovered a molecular regulator that allows salmonella bacteria to switch from actively causing disease to lurking in a chronic but asymptomatic state called a biofilm.Tricked-Out Immune Cells Could Attack Cancer New cell-engineering technique may lead to precision immunotherapies.Neural Networks Adapt to the Presence of a Toxic HIV Protein HIV-associated neurocognitive disorders (HAND) afflict approximately half of HIV infected patients.HIV Protein Manipulates Hundreds of Human Genes Findings search for new or improved treatments for patients with AIDS.Breaking the Brain’s Garbage Disposal The children’s ataxia gene problem turned out to be not such a big deal genetically — it was such a slight mutation that it barely changed the way the cells made the protein. Flesh-Eating Bacteria Work Together Scientists recently discovered different strains of deadly flesh-eating bacteria working together to spread infection and they now have a better understanding of the role of the toxins they produce. The discovery could change how the illness and other diseases are treated.
Towards a Disease-specific Biomarker Signature for Neuromuscular Disorders Professor Kay Ohlendieck, National University of Ireland, speaking at Molecular Diagnostics Europe 2012.
Chemiluminescence-Based Biosensors for Point-of-Care Multiplex Sensing as a Companion Diagnostics in Personalized Medicine Professor Aldo Roda, University of Bologna, speaking at Advances in Biodetection and Biosensors 2012.
Highly Sensitive and Rapid Magnetic Biosensors Wendy Dittmer, Philips Research, speaking at Advances in Biodetection ad Biosensors 2012.
Capacitive Immunosensors – A Tool for Detection Where Sensitivity of Conventional ELISA is Not Sufficient Prof. Bo Mattiasson, Lund University, speaking at Advances in Biodetection and Biosensors 2012.
Antibodies and Antibody RNase Fusion Proteins Targeting CD30+ Lymphoma Thomas Schirrmann PhD, Technische Universitaet Braunschweig, speaking at BioProcessing, Biologics & Biotherapeutics Congress 2011.
Glycosylation of IgG antibodies: a Critical Quality Attribute (CQA) Professor Roy Jefferis, College of Medical and Dental Sciences, University of Birmingham, speaking at BioProcessing, Biologics & Biotherapeutics Congress 2011.
Biosimilars and the US-legislation: Analytical and Clinical Challenges Dr William Egan, Vice President in the Consulting Division of PharmaNet, speaking at BioProcessing, Biologics & Biotherapeutics Congress 2011.
Protein and Peptide Arrays for Studying Autoimmunity Professor Paul J. (P.J.) Utz, Stanford University, speaking at Microarray World Congress.
Validation of Biomarkers In Tissue Dr Stephen M. Hewitt, National Cancer Institute, speaking at Microarray World Congress 2011.